✓ No loaded language, vague sourcing, or framing detected.
Abbott Laboratories has agreed to pay $385 million to settle allegations related to its manufacturing plant that produced contaminated baby formula, which is believed to have caused infant deaths. The contamination resulted in the temporary closure of the facility in 2022 and a recall of multiple infant formula brands.
Our neutral summary
Abbott Laboratories has agreed to pay $385 million to settle allegations related to its manufacturing plant that produced contaminated baby formula, which is believed to have caused infant deaths. The contamination resulted in the temporary closure of the facility in 2022 and a recall of multiple infant formula brands.
The reporting belongs to The Hill; we don't reproduce it.
No note attached
on this article.
Abbott agrees to settle DOJ lawsuit over baby formula plant contamination
Abbott Laboratories to pay $385 million to settle DOJ lawsuit over baby formula contamination